78 related articles for article (PubMed ID: 8096430)
1. Long-term imipramine effects are prevented by NMDA receptor blockade.
De Montis MG; Gambarana C; Meloni D; Taddei I; Tagliamonte A
Brain Res; 1993 Mar; 606(1):63-7. PubMed ID: 8096430
[TBL] [Abstract][Full Text] [Related]
2. Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats.
Meloni D; Gambarana C; De Montis MG; Dal Prá P; Taddei I; Tagliamonte A
Pharmacol Biochem Behav; 1993 Oct; 46(2):423-6. PubMed ID: 7903459
[TBL] [Abstract][Full Text] [Related]
3. The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole.
D'Aquila PS; Sias A; Gessa GL; Serra G
Eur J Pharmacol; 1992 Dec; 224(2-3):199-202. PubMed ID: 1361447
[TBL] [Abstract][Full Text] [Related]
4. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors.
Ferré S; Giménez-Llort L; Artigas F; Martínez E
Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043
[TBL] [Abstract][Full Text] [Related]
5. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
6. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
7. Role of alpha 1 receptors in the behavioural supersensitivity to D2 agonists induced by chronic treatment with imipramine.
D'Aquila PS; Collu M; Gessa GL; Serra G
Pharmacol Res; 1992 Jan; 25(1):95-101. PubMed ID: 1346718
[TBL] [Abstract][Full Text] [Related]
8. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
Boldry RC; Chase TN; Engber TM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390
[TBL] [Abstract][Full Text] [Related]
9. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
10. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
LaHoste GJ; Yu J; Marshall JF
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
[TBL] [Abstract][Full Text] [Related]
11. NMDA receptor inhibition prevents tolerance to cocaine.
De Montis MG; Devoto P; Meloni D; Gambarana C; Giorgi G; Tagliamonte A
Pharmacol Biochem Behav; 1992 May; 42(1):179-82. PubMed ID: 1356273
[TBL] [Abstract][Full Text] [Related]
12. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
[TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
Domino EF; Sheng J
J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
[TBL] [Abstract][Full Text] [Related]
14. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
15. Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
Cory-Slechta DA; Widzowski DV
Brain Res; 1991 Jul; 553(1):65-74. PubMed ID: 1681979
[TBL] [Abstract][Full Text] [Related]
16. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
18. MK-801 reverses effects of chronic levodopa on D1 and D2 dopamine agonist-induced rotational behavior.
Boldry RC; Papa SM; Kask AM; Chase TN
Brain Res; 1995 Sep; 692(1-2):259-64. PubMed ID: 8548312
[TBL] [Abstract][Full Text] [Related]
19. Glutamate N-methyl-D-aspartate and dopamine receptors have contrasting effects on the limbic versus the somatosensory cortex with respect to amphetamine-induced neurodegeneration.
Bowyer JF; Delongchamp RR; Jakab RL
Brain Res; 2004 Dec; 1030(2):234-46. PubMed ID: 15571672
[TBL] [Abstract][Full Text] [Related]
20. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated.
Ogren SO; Goldstein M
Neuropsychopharmacology; 1994 Nov; 11(3):167-77. PubMed ID: 7865098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
